世界共享医疗组织

Domestic

The "International Forum on Tumor Targeting Therapy and the Annual Meeting of the Minimally Invasive and Targeted Therapy Committee of Hebei Province and Medical Project Launching Ceremony of WHSO" was successfully held!2019-01-03


The incidence of malignant tumors is increasing year by year, and the clinical hazards are large, which seriously affects the quality of life of patients and brings a heavy social burden. With the rapid advancement of medical science and technology, the accumulation of clinical practic, and treatment mode shifts from doctor-centered to patient-centered, the status of minimally invasive treatment and targeted therapy in malignant tumor treatment has rapidly increased. National clinical practice guidelines have also increased the proportion of minimally invasive treatment and targeted therapy based on the original three axesof surgery, radiotherapy and chemotherapy. The combination of standardized treatment and individualized treatment, systemic treatment and local treatment greatly improves the quality of life of patients and prolongs the survival of patients. The "International Forum on Tumor Targeting Therapy and the Annual Meeting of the Minimally Invasive and Targeted Therapy Committee of Hebei Province and Medical Project Launching Ceremony of WHSO" was held on November 18, 2018 at the Ximei Wuzhou International Hotel in Shijiazhuang. Everyone gathered to share an academic feast.


The meeting began on time on November 18th, at 8:45. First, the opening speech was given by the director of the Minimally Invasive and Targeted Therapy Committee of Hebei Province and the committee member of the World Health Sharing Organization, Professor An Yonghui; Professor Israel Barken, executive committee member of the World Health Sharing Organization, presided over the awarding ceremony for the sharing medical project of the WHSO, and issued certificates to its members. Zhang Futong and Li Xiuli, directors of the WHSO, issued certificates to the committee members.


Later, Professor Israel Barken of the University of California, Professor Qian Niansong of the PLA General Hospital, and Professor Ma Guoxin of the Fourth Hospital of Hebei Medical University respectively give the speech to describe the new ideas of combining tumor cryoablation with immunotherapy and the molecular mechanism of anti-angiogenic drugs and anti-angiogenic drugs in the treatment of non-small cell lung cancer. Finally, Professor Li Na of the First Hospital of Hebei Medical University Cancer Center shared the cases of patients with advanced gallbladder cancer who received good results after cryoablation, arterial interventional embolization and targeted therapy.


Tumor-related medical personnel from all over the country attended the conference and listened carefully to the experts. The number of participants far exceeded expectations, fully reflecting the lofty medical ethics of doctors who treat patients as themselves in the field of oncology in Hebei Province and the spiritual outlook that constantly demands to improve their own level. The meeting came to a close in the heated discussion. The Cancer Treatment Center of the First Hospital of Hebei Medical University is willing to work together with colleagues from all walks of life to push the province's cancer treatment level to a new height and benefit the majority of cancer patients.



Previous:第一页 Next:最后一页